메뉴 건너뛰기




Volumn 2, Issue 1, 2000, Pages 11-12

Xenobiotics, dietary interventions, and genetically mediated therapies

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN;

EID: 0034137208     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-000-0051-x     Document Type: Note
Times cited : (2)

References (12)
  • 1
    • 0004270125 scopus 로고
    • edn 5. Baltimore: Williams & Wilkins
    • Kaplan NM: Clinical Hypertension, edn 5. Baltimore: Williams & Wilkins; 1990: 163-267.
    • (1990) Clinical Hypertension , pp. 163-267
    • Kaplan, N.M.1
  • 2
    • 0025333289 scopus 로고
    • Evolution of the P450 gene superfamily: Animal-plant 'warfare,' molecular drive and human genetic differences in drug oxidation
    • Gonzalez FJ, Nebert DW: Evolution of the P450 gene superfamily: animal-plant 'warfare,' molecular drive and human genetic differences in drug oxidation. Trends Genet 1990, 6: 182-186.
    • (1990) Trends Genet , vol.6 , pp. 182-186
    • Gonzalez, F.J.1    Nebert, D.W.2
  • 3
    • 0030935831 scopus 로고    scopus 로고
    • Genetic polymorphisms in the human drug-metabolizing enzymes: Potential uses of reverse genetics to identify genes of toxicological relevance
    • Puga A, Nebert DW, McKinnon RA, Menon AG: Genetic polymorphisms in the human drug-metabolizing enzymes: potential uses of reverse genetics to identify genes of toxicological relevance. Crit Rev Toxicol 1997, 27: 199-222.
    • (1997) Crit Rev Toxicol , vol.27 , pp. 199-222
    • Puga, A.1    Nebert, D.W.2    McKinnon, R.A.3    Menon, A.G.4
  • 4
    • 0033005767 scopus 로고    scopus 로고
    • Enhanced blood pressure response to mild sodium reduction in subjects with the 235T variant of the angiotensinogen gene
    • Hunt SC, Geleijnse JM, Wu LL, et al.: Enhanced blood pressure response to mild sodium reduction in subjects with the 235T variant of the angiotensinogen gene Am J Hypertens 1999, 12: 460-466.
    • (1999) Am J Hypertens , vol.12 , pp. 460-466
    • Hunt, S.C.1    Geleijnse, J.M.2    Wu, L.L.3
  • 5
    • 0031656257 scopus 로고    scopus 로고
    • Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: Trials of hypertension prevention, phase II
    • Hunt SC, Cook NR, Oberman A, et al.: Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II. Hypertension 1998, 32: 393-401.
    • (1998) Hypertension , vol.32 , pp. 393-401
    • Hunt, S.C.1    Cook, N.R.2    Oberman, A.3
  • 6
    • 0033068862 scopus 로고    scopus 로고
    • Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: Trials of hypertension prevention, phase II [review]
    • Schork NJ: Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II [review]. Curr Hypertens Rep 1999, 1:11-12.
    • (1999) Curr Hypertens Rep , vol.1 , pp. 11-12
    • Schork, N.J.1
  • 7
    • 0030932384 scopus 로고    scopus 로고
    • Functional foods
    • Farr DR: Functional foods. Cancer Lett 1997, 114: 59-63.
    • (1997) Cancer Lett , vol.114 , pp. 59-63
    • Farr, D.R.1
  • 8
    • 0032548138 scopus 로고    scopus 로고
    • Nutriceuticals for cardiovascular health
    • Cooke JP: Nutriceuticals for cardiovascular health. Am J Cardiol 1998, 82(10A):42S-46S.
    • (1998) Am J Cardiol , vol.82 , Issue.10 A
    • Cooke, J.P.1
  • 11
    • 84882469134 scopus 로고    scopus 로고
    • Edited by Simopoulos AP, Nestel PJ. Karger: Basel
    • Genetic Variation and Dietary Response, vol 80. Edited by Simopoulos AP, Nestel PJ. Karger: Basel; 1997.
    • (1997) Genetic Variation and Dietary Response , vol.80


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.